Market News

ImmunityBio Stock Climbs As FDA Accepts Expanded Use Filing For Bladder Cancer Drug

Inside The AI Chip Crunch: Intel Pressures PC Makers To Upgrade Fast

Rosenblatt Maintains Buy on Synaptics, Raises Price Target to $180

Arcos Dorados Posts Strong First-Quarter 2026 Profit and Revenue Growth - TipRanks

Guardant Health Announces FDA Approval Of The Company's Liquid CDx To Advance Blood-Based Comprehensive Genomic Testing

Stifel Maintains Buy on CrowdStrike Holdings, Raises Price Target to $660

Klarna Unveils Klarna Shopping Search App In ChatGPT, Bringing Real-Time Product Discovery Directly Into Conversation

Zeta Global Momentum Score Surges As It Joins Snowflake-Led OSI Push To Standardize Enterprise AI Data

HC Wainwright & Co. Reiterates Buy on Uranium Energy, Maintains $26.75 Price Target

JB Pritzker Hails Rivian R2 Production, Says He Has Reserved The 'Made In Illinois' Tesla Model Y Rival

Five-section trams from PC TS and TMH cleared for serial production - rollingstockworld.com

China, United States Expand Trade Cooperation With Boeing Jet Deal, Beef Export Resumption And Rare Earths Discussions

'Marc Rowan Accused Of Misusing Apollo Resources For Political Work' - FT

Triple Flag Precious Metals (TFPM) Reports Record GEOs for Q1 - Insider Monkey

SiTime Prices Upsized $1.2B Zero-Coupon Convertible Senior Notes To Fund Renesas Timing Assets Acquisition

Golar LNG (GLNG) Set to Report Strong Q1 Earnings Amid LNG Suppl - GuruFocus

Paramount Skydance Expects To Achieve About 30% Of Expected Synergies Of Over $6B By First Year Following Closing Of WBD

$100 Invested In Synopsys 10 Years Ago Would Be Worth This Much Today

Rocket Lab Shares Rise Over 10% After Key Trading Signal

Truist Securities Assumes Rapport Therapeutics at Buy, Raises Price Target to $56